Catalyzed by the pandemic, the pharma industry quickly progressed from being digitally agnostic to a state of preparedness. The shift required the industry to experiment with technology in its customer-facing plans, which resulted – in many cases – a creation of random acts of digital, often without a cohesive overarching strategy.
Can pharma do better? The answer lies in understanding the utility of their digital assets while building a mindset to transform, and ensuring that teams within the organization do not work at cross-purposes.
Archis Joshi – Commercial Head, Sales and Marketing, Dr. Reddy’s, K. Satya Mahesh – Former head of commercial excellence at Emcure, Dr. Mehul Shukla – Head of Commercial Excellence at Cipla discuss in a session moderated by Anup Soans – Editor, MedicinMan
First published in MedicinMan on 26th Ocotober 2022